Antitumor Agents: Development of Highly Potent Glycosidic Duocarmycin Analogues for Selective Cancer Therapy
Authors:
- Lutz F. TietzeLTLutz F. Tietze
- Felix MajorFMFelix Major
- 29 September 2006
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 45 (39) , 6574-6577
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Eine vollsynthetische Vakzine aus einem tumorassoziierten Glycopeptid-Antigen und einem T-Zell-Epitop zur Induktion einer hochspezifischen humoralen ImmunantwortAngewandte Chemie, 2005
- Synthetische Vakzine aus tumorassoziierten MUC1‐Glycopeptid‐Antigenen und RinderserumalbuminAngewandte Chemie, 2005
- A Fully Synthetic Vaccine Consisting of a Tumor‐Associated Glycopeptide Antigen and a T‐Cell Epitope for the Induction of a Highly Specific Humoral Immune ResponseAngewandte Chemie International Edition, 2005
- Synthetic Vaccines Consisting of Tumor‐Associated MUC1 Glycopeptide Antigens and Bovine Serum AlbuminAngewandte Chemie International Edition, 2005
- Generation of an Intensely Potent Anthracycline by a Monoclonal Antibody−β-Galactosidase ConjugateBioconjugate Chemistry, 2005
- Synthesis and Enzyme-Specific Activation of Carbohydrate−Geldanamycin Conjugates with Potent Anticancer ActivityJournal of Medicinal Chemistry, 2004
- β-Glucuronidase-Cleavable Prodrugs of O6-Benzylguanine and O6-Benzyl-2‘-deoxyguanosineJournal of Medicinal Chemistry, 2004
- Protein Kinase Inhibitors: Insights into Drug Design from StructureScience, 2004
- Novel Peptide Conjugates for Tumor-Specific ChemotherapyJournal of Medicinal Chemistry, 2001
- Neighboring Carbon and Hydrogen. Li. Dienones from Ar1[UNK]-3 Participation. Isolation and Behavior of Spiro(2,5)octa-1,4-diene-3-oneJournal of the American Chemical Society, 1963